IDEXX LABORATORIES INC /DE Interest Income, Deposits with Financial Institutions
IDEXX LABORATORIES INC /DE (IDXX) reported Interest Income, Deposits with Financial Institutions of $436.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-20.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeDepositsWithFinancialInstitutions · last filed 2012-04-20
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for the quarter ending 2012-03-31 was $436.00K, a 18.16% increase year-over-year.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for the quarter ending 2011-12-31 was $506.00K, a 50.60% increase year-over-year.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for the quarter ending 2011-09-30 was $450.00K, a 230.88% increase year-over-year.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for the quarter ending 2011-06-30 was $419.00K, a 203.62% increase year-over-year.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for fiscal 2011 was $1.74M, a 163.05% increase from fiscal 2010.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for fiscal 2010 was $663.00K, a 36.42% increase from fiscal 2009.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for fiscal 2009 was $486.00K, a 79.05% decline from fiscal 2008.
- IDEXX LABORATORIES INC /DE interest income, deposits with financial institutions for fiscal 2008 was $2.32M.
| Period end | Interest Income, Deposits with Financial Institutions 3 month | Interest Income, Deposits with Financial Institutions 6 month | Interest Income, Deposits with Financial Institutions 9 month | Interest Income, Deposits with Financial Institutions 12 month |
|---|---|---|---|---|
| 2012-03-31 | $436.00K 10-Q · filed 2012-04-20 | $942.00K derived: sum of 2 quarters · filed 2012-04-20 | $1.39M derived: sum of 3 quarters · filed 2012-04-20 | $1.81M derived: sum of 4 quarters · filed 2012-04-20 |
| 2011-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $956.00K derived: sum of 2 quarters · filed 2012-02-17 | $1.38M derived: sum of 3 quarters · filed 2012-02-17 | $1.74M 10-K · filed 2012-02-17 |
| 2011-09-30 | $450.00K 10-Q · filed 2011-10-21 | $869.00K derived: sum of 2 quarters · filed 2011-10-21 | $1.24M 10-Q · filed 2011-10-21 | $1.57M derived: sum of 4 quarters · filed 2012-04-20 |
| 2011-06-30 | $419.00K 10-Q · filed 2011-07-22 | $788.00K 10-Q · filed 2011-07-22 | $1.12M derived: sum of 3 quarters · filed 2012-04-20 | $1.26M derived: sum of 4 quarters · filed 2012-04-20 |
| 2011-03-31 | $369.00K 10-Q · filed 2012-04-20 | $705.00K derived: sum of 2 quarters · filed 2012-04-20 | $841.00K derived: sum of 3 quarters · filed 2012-04-20 | $979.00K derived: sum of 4 quarters · filed 2012-04-20 |
| 2010-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $472.00K derived: sum of 2 quarters · filed 2012-02-17 | $610.00K derived: sum of 3 quarters · filed 2012-02-17 | $663.00K 10-K · filed 2012-02-17 |
| 2010-09-30 | $136.00K 10-Q · filed 2011-10-21 | $274.00K derived: sum of 2 quarters · filed 2011-10-21 | $327.00K 10-Q · filed 2011-10-21 | $465.00K derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $138.00K 10-Q · filed 2011-07-22 | $191.00K 10-Q · filed 2011-07-22 | $329.00K derived: sum of 3 quarters · filed 2012-02-17 | $377.00K derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $53.00K 10-Q · filed 2011-04-21 | $191.00K derived: sum of 2 quarters · filed 2012-02-17 | $239.00K derived: sum of 3 quarters · filed 2012-02-17 | $295.00K derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $186.00K derived: sum of 2 quarters · filed 2012-02-17 | $242.00K derived: sum of 3 quarters · filed 2012-02-17 | $486.00K 10-K · filed 2012-02-17 |
| 2009-09-30 | $48.00K 10-Q · filed 2010-10-22 | $104.00K derived: sum of 2 quarters · filed 2010-10-22 | $348.00K 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $56.00K 10-Q · filed 2010-07-23 | $300.00K 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $2.32M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |